Food Safety News6d
Outgoing FDA Commissioner Robert Califf discusses agency’s uncertain future
Dr. Robert M. Califf bid farewell to his role as Commissioner of the U.S. Food and Drug Administration in a reflective post ...
FierceBiotech1d
FDA’s diagnostics CMO named interim agency commissioner
The FDA has tapped Sara Brenner to serve as acting commissioner as it awaits new leadership from the Trump administration to ...
Food Processing6d
FDA Commissioner Califf’s Advice to His Successor and RFK Jr.
The Los Angeles Times had an insightful article on the barriers to change and political threats the agency faces -- from the ...
Food Safety News4d
Acting FDA Commissioner named
Dr. Sara Brenner has been named acting commissioner of the Food and Drug Administration. Brenner replaces Dr. Robert Califf. The announcement was made ...
JD Supra8h
FDA Advances Proposal To Lower Nicotine in Cigarettes
In the final days of the Biden administration, the Food and Drug Administration (FDA) has taken a significant step toward reducing nicotine levels ...
Texas Public Radio1d
The FDA pulls key DEI initiative for cancer studies from its website
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
Truthout1d
Trump Aims to Overhaul the FDA. What Does That Mean for Public Health?
Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon ...
NPR3d
The FDA pulls key DEI initiative for cancer studies from its website
Sponsor Message "It's hard for me to understand why anyone would be opposed to clinical trials including the variety of people for whom the drug or device is intended," Dr. Robert Califf ...
Star Tribune4d
FDA floats plan to make cigarettes nonaddictive, but its fate rests with Trump
This action, if finalized, could save many lives and dramatically reduce the burden of severe illness and disability,'' FDA Commissioner Robert Califf told reporters Wednesday. Under the agency's ...
LAist3d
The FDA pulls key DEI initiative for cancer studies from its website
"It's hard for me to understand why anyone would be opposed to clinical trials including the variety of people for whom the drug or device is intended," Dr. Robert Califf, the most recent FDA ...